Rebound Nasal Congestion with Nighttime-Only Azelastine Use

Understanding the Mechanism

• Azelastine is an H1-receptor antagonist with mast-cell stabilizing and anti-inflammatory properties, reducing symptoms in patients with nasal congestion, according to the American Academy of Allergy, Asthma, and Immunology 1, 2, 3
• The American College of Allergy, Asthma, and Immunology states that azelastine does not act as a vasoconstrictor on nasal blood vessels, which is the mechanism that leads to rebound congestion with topical decongestants 4, 5

Rebound Congestion: What Actually Causes It

• The American Academy of Otolaryngology recommends that only topical decongestants like oxymetazoline and xylometazoline cause rebound congestion through activation of alpha-adrenergic receptors, leading to tachyphylaxis and reduced mucociliary clearance in patients 4
• The onset of rebound congestion can occur as early as the third or fourth day of continuous topical decongestant use, as stated by the American Rhinologic Society 4
• Intranasal corticosteroids and antihistamines like azelastine do not cause rebound congestion because they work through anti-inflammatory mechanisms rather than vasoconstriction, according to the American College of Allergy, Asthma, and Immunology 4, 5

Clinical Use of Azelastine

• Standard dosing is 2 sprays per nostril twice daily for patients 12 years and older, though once-daily or as-needed use is also effective, as recommended by the American Academy of Allergy, Asthma, and Immunology 1
• Most common side effects are bitter taste and somnolence, not rebound congestion, in patients using azelastine, according to the American College of Allergy, Asthma, and Immunology 1, 3

Important Distinction for Patients with Prior Decongestant Use

• Switching to azelastine will not perpetuate or cause rebound congestion because the mechanisms are entirely different, as stated by the American College of Allergy, Asthma, and Immunology 4, 5
• If a patient has existing rhinitis medicamentosa from prior decongestant overuse, azelastine can be part of the treatment regimen alongside intranasal corticosteroids without risk of worsening the condition, according to the American Rhinologic Society 4

Key Clinical Pitfall to Avoid

• Do not confuse azelastine with topical decongestants - they are fundamentally different drug classes with different mechanisms and safety profiles, as recommended by the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology 1, 4, 5